Marketing messages in pharmacological papers and scientific chapters: the case of palmitoylethanolamide and its formulations
ReviewHumans
- Design
- Review
- Subjects
- Letter to the editor
- Dose used in the study
- Not applicable
- Duration
- Not applicable
- What was measured
- A critique of how branded micronised and ultramicronised formulations are presented in pharmacology papers and book chapters
What the authors reported
The author argues that some scientific papers on palmitoylethanolamide carry marketing messages for particular formulations. A reply from Cuzzocrea was published in the same journal (PMID 24852086). A second letter by the same author in Pain, 2016, made a similar point about a branded name in an animal study (PMID 26871399).
Limits of this study
Opinion letters, not data. Listed so readers know that the formulation claims discussed on this site have been publicly disputed within the literature. Read with the replies.
Source
PubMed 24769196 · doi:10.1016/j.phrs.2014.04.007
Entry checked against the PubMed record; letters have no abstract on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.